Find Funding Opportunities

The purpose of this time-sensitive Request for Information (RFI) is to solicit public input to the NINDS regarding the challenges and opportunities in fundamental neuroscience research to best understand the normal development, structure, and function of nervous systems.

RE-JOIN Technical Assistance Webinar

The purpose of this notice is to correct the Award Project Period Information for Funding Opportunity Announcement (FOA) PAS-19-316 "Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional). According to statutory guidelines, award periods normally may not exceed 2 years for Phase I and 3 years for Phase II. As such, NIA has changed the award period for Phase I from 1 year to 2 years and the award period for Phase II from 2 years to 3 years.

The purpose of this notice is to correct the Award Project Period Information for Funding Opportunity Announcement (FOA) PAS-19-317, "Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional). Specifically, according to statutory guidelines, award periods normally may not exceed 2 years for Phase I and 3 years for Phase II. As such, NIA has changed the award period for Phase I from 1 year to 2 years and the award period for Phase II from 2 years to 3 years.

This notice describes opportunities available to CRCNS grantees to support the use of such resources. The Cloud Access Program (NSF) and the STRIDES Initiative (NIH) have established partnerships with commercial cloud service providers to provide awardees with cost-effective, flexible access to cloud-based resources. The Partnership to Advance Throughput Computing (PATh) facilitates access to distributed high throughput computing technologies and services. These opportunities are now available to active CRCNS grantees as described below.

The aim of this Notice of Special Interest (NOSI)is to advance basic and clinical research on the causes and consequences of sleep deficiency and circadian clock dysfunction in Alzheimer's disease (AD) and Alzheimers disease-related dementias (ADRD), and the roles of sleep and the circadian clock as modifiers of the onset and progression of neurodegeneration.

The purpose of this time-sensitive Request for Information (RFI) is to seek input from people living with amyotrophic lateral sclerosis (ALS), families, caregivers, advocates, scientists, clinicians, and the broader community on the most important knowledge gaps and promising research opportunities that will lead to the discovery of effective interventions for the diagnosis, treatment, management, prevention, or cure of ALS.

The purpose of this funding opportunity announcement is to support research that uses human tissue or cells to generate comprehensive datasets for the discovery and characterization of functional genetic elements, epigenetic signatures, and molecular/cellular pathways that underlie human pain transduction, transmission, and processing. This FOA will support concerted multidisciplinary team science efforts that apply large-scale high-throughput approaches on tissues involved in human pain processing as part of the NIH HEAL Initiatives Program to Reveal and Evaluate Cells-to-gene Information that Specify Intricacies, Origins, and the Nature of Human Pain (PRECISION Human Pain). U19 Centers will operate as a cooperative network to promote collaboration and coordination of research activities. U19 Centers will also coordinate with the U24 HEAL Initiative: Human Pain-associated Genes & Cells Data Coordination and Integration Center in order to extract, accumulate, organize, annotate, and link the datasets generated by this U19 research program.

The goal of this funding opportunity announcement is to support a Human Pain-associated Genes & Cells Data Coordination and Integration Center as part of the NIH HEAL Initiatives Program to Reveal and Evaluate Cells-to-gene Information that Specify Intricacies, Origins and the Nature of Human Pain (PRECISION Human Pain). The Data Coordination and Integration Center will extract, accumulate, organize, annotate, and link growing bodies of information related to core datasets generated by companion U19 Centers for Discovery and Functional Evaluation of Human Pain-associated Genes & Cells, which include the characterization of functional genetic elements, epigenetic signatures, and molecular/cellular pathways that underlie human pain signal transduction, transmission and processing. The Human Pain-associated Genes & Cells Data Coordination and Integration Center will lead efforts to establish spatial and semantic standards for managing heterogeneous human pain-associated data types and information, collect and register multimodal human pain-associated data to common neural tissue coordinate systems, and establish a web-accessible information system that can be widely used throughout the research community. A central goal of the PRECISION Human Pain network is to act as a data repository and generate a comprehensive, integrated datasets on human genes and cellular function phenotypes underlying the heterogeneity, pathogenesis and susceptibility to specific pain conditions.

The purpose of this notice is to inform potential applicants to the National Institute on Aging (NIA); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Center for Complementary and Integrative Health (NCCIH); National Institute of Dental and Craniofacial Research (NIDCR); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); and the National Institute of Neurological Disorders and Stroke (NINDS) of areas of pain research that are of special interest to these Institutes. The Institutes are interested in receiving applications for potential funding in FY22 that seek to provide new knowledge of the mechanistic complexity of pain that may lead to more effective, non-addictive treatments for pain conditions related to the missions of these Institutes. This Notice is also intended to inform investigators of the special research opportunities available through the multi-Institute and Center Helping to End Addiction Long-term (HEAL) Initiative.